We are live on
!
Find out more
FCMI
Foresite Capital Management I Portfolio holdings
AUM
$21.4M
1-Year Est. Return
80.48%
This Fund
S&P 500
This Quarter
Est. Return
+51.28%
1 Year Est. Return
-80.48%
3 Year Est. Return
-40.72%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$552M
AUM Growth
–
Cap. Flow
+$435M
Cap. Flow
% of AUM
78.85%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
10x Genomics
TXG
|
+$435M |
| 2 |
XLRN
Acceleron Pharma
XLRN
|
+$365K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
10x Genomics
TXG
$5.55B
| $552M | 99.92% |
+7,235,396
| New | +$435M |
|
|
XLRN
2
DELISTED
Acceleron Pharma
XLRN
| $424K | 0.08% |
+8,000
| New | +$365K |
|
Similar funds
A
CVGI
AEPI
AGDR
N
WL
NVPX
SVGI
Foresite Capital Management I's Q4 2019 Portfolio in Review
Q4 2019 is the first quarter with a 13F filing on record for Foresite Capital Management I, which disclosed 2 positions worth $552M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is 10x Genomics: 7,235,396 shares worth $552M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Foresite Capital Management I's largest Q4 2019 buy was 10x Genomics: 7,235,396 shares worth $552M.
- Foresite Capital Management I's ten largest holdings make up 100% of its $552M portfolio in Q4 2019.
- Foresite Capital Management I disclosed 2 positions in Q4 2019, its first 13F filing on record.
Based on Foresite Capital Management I's 13F filing for Q4 2019, filed 5 Feb 2020.